Leaders of major insulin makers and pharmacy benefit managers traded blame for the life-saving drug s high price while testifying at a US Senate committee hearing.
Leaders of major insulin
makers and pharmacy benefit managers traded blame for the
life-saving drug s high price on Wednesday while testifying at a
U.S. Senate committee hearing on making it more. | June 16, 2023